Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures

Neurochemistry International

Volumn 49, Issue 6, 2006, Pages 568-576

  Antonelli, T ^a   Tomasini, M C ^a   Tattoli, M ^b   Cassano, T ^c   Finetti, S ^a   Mazzoni, E ^a   Trabace, L ^c   Carratu M R ^b   Cuomo, V ^d   Tanganelli, S ^a   Ferraro, L ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Basal and K+ evoked glutamate levels; Maternal marijuana exposure; SR141716A

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AFFECTING AGENT; CARBON MONOXIDE; GLUTAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN NERVE CELL; CANNABIS ADDICTION; CONTROLLED STUDY; CYTOTOXICITY; EVOKED RESPONSE; FEMALE; GESTATION PERIOD; LEARNING DISORDER; MEMORY DISORDER; NERVE CELL CULTURE; NEUROTOXICITY; NEUROTRANSMISSION; NEWBORN; NONHUMAN; POTASSIUM CURRENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANIMALS; BENZOXAZINES; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CELLS, CULTURED; CEREBRAL CORTEX; EXTRACELLULAR SPACE; FEMALE; GLUTAMATES; MORPHOLINES; NAPHTHALENES; PIPERIDINES; POTASSIUM; PREGNANCY; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; REPRODUCTION;

CANNABIS SATIVA;

EID: 33749566840     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.04.012     Document Type: Article

References (66)

1. Alho H., Ferrarese C., Vicini S., and Vaccarino F. Subsets of GABAergic neurons in dissociated cell cultures of neonatal rat cerebral cortex show co-localization with specific modulator peptides. Dev. Brain Res. 39 (1988) 193-204
2. Ang E.-S.-B.-C., Haydar T.-F., Gluncic V., and Rakic P. Four-dimensional migratory coordinates of GABAergic interneurons in the developing mouse cortex. J. Neurosci. 23 (2003) 5805-5815
3. Antonelli T., Tanganelli S., Tomasini M.-C., Finetti S., Trabace L., Steardo L., Sabino V., Carratu' M.-R., Cuomo V., and Ferraro L. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]- 1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat. Neuroscience 124 (2004) 367-375
4. Antonelli T., Tomasini M.-C., Tattoli M., Cassano T., Tanganelli S., Finetti S., Mazzoni E., Trabace L., Steardo L., Cuomo V., and Ferraro L. Prenatal exposure to the CB1 receptor agonist WIN-55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb. Cortex 15 (2005) 2013-2020
5. Auclair N., Otani S., Soubrie' P., and Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 83 (2000) 3287-3293
6. Begg M., Pacher P., Batkai S., Osei-Hyiaman D., Offertaler L., Mo F.-M., Liu J., and Kunos G. Evidence for novel cannabinoid receptors. Pharmacol. Ther. 106 (2005) 133-145
7. Bernard C., Milh M., Morozov Y.-M., Ben-Ari Y., Freund T.-F., and Gozlan H. Altering cannabinoid signaling during development disrupts neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9388-9393
8. Berrendero F., Garcia-Gil L., Hernandez M.-L., Romero J., Cebeira M., de Miguel R., Ramos J.-A., and Fernandez-Ruiz J.-J. Localization of mRNA expression and activation of signal transduction mechanism for cannabinoid receptor in rat brain during fetal development. Development 125 (1998) 3179-3188
9. Berrendero F., Sepe N., Ramos J.-A., Di Marzo V., and Fernandez-Ruiz J.-J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33 (1999) 181-191
10. Breivogel C.-S., Griffin G., Di Marzo V., and Martin B.-R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 60 (2001) 155-163
11. Bridges R.J., Stanley M.-S., Anderson M.-W., Cotman C.-W., and Chamberlin A.-R. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem. 34 (1991) 717-725
12. Buckley N.-E., Hansson S., Harta G., and Mezey E. Expression of the CB1 and CB2 receptor messenger RNAS during embryonic development in the rat. Neuroscience 82 (1998) 1131-1149
13. Cagiano R., Ancona D., Cassano T., Tattoli M., Trabace L., and Cuomo V. Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring. Br. J. Pharmacol. 125 (1998) 909-915
14. Cole P.V. Comparative effects of atmospheric pollution and cigarette smoking on carboxyhaemoglobin levels in man. Nature 255 5511 (1975) 699-701
15. Compton D.R., Gold L.H., Ward S.J., Balster R.L., and Martin B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263 (1992) 1118-1126
16. Day N., Richardson G., Goldschmidt L., Robles N., Taylor P., Stoffer D., Cornelius M., and Geva D. The effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol. Teratol. 16 (1994) 169-175
17. Denckla M.-B. Measurement of executive function. In: Lyon G.R. (Ed). Frames of Reference for the Assessment of Learning Disabilities: New Views on Measurement Issues (1993), Paul H. Brookes, Baltimore 117-142
18. Di Giovanni V., Cagiano F., De Salvia M.-A., Giustino A., Lacomba C., Renna G., and Cuomo V. Neurobehavioral changes produced in rats by prenatal exposure to carbon monoxide. Brain Res. 616 (1993) 126-131
19. Fechter L.D., and Annau Z. Toxicity of mild prenatal carbon monoxide exposure. Science 197 4304 (1977) 680-682
20. Fernandez-Ruiz J.J., Berrendero F., Hernandez M.-L., Romero J., and Ramos J.A. Role of endocannabinoids in brain development. Life Sci. 65 (1999) 725-736
21. Fernandez-Ruiz J.J., Berrendero F., Hernandez M.-L., and Ramos J.-A. The endogenous cannabinoid system and brain development. Trends Neurosci. 23 (2000) 14-20
22. Fernandez-Ruiz J., Gomez M., Hernandez M., de Miguel R., and Ramos J.-A. Cannabinoids and gene expression during brain development. Neurotoxicol. Res. 6 (2004) 389-401
23. Ferraro L., Tomasini M.-C., Gessa G.-L., Bebe B.-W., Tanganelli S., and Antonelli T. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb. Cortex 11 (2001) 728-733
24. Fried P.-A., Watkinson B., Grant A., and Knights R.K. Changing patterns of soft drug use prior to and during pregnancy: a prospective study. Drug Alcohol Depend. 6 (1980) 323-343
25. Fried P.-A., and Makin J.-E. Neonatal behavioral correlates of prenatal exposure to marijuana, cigarettes and alcohol in a low risk population. Neurotoxicol. Teratol. 9 (1987) 1-7
26. Fried P.-A., Watkinson B., Dillon R.-F., and Dulberg C.-S. Neonatal neurological status in a low risk population after prenatal exposure to cigarettes, marijuana and alcohol. J. Dev. Behav. Pediatr. 8 (1987) 318-326
27. Fried P.-A., and Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes and alcohol. J. Dev. Behav. Pediatr. 11 (1990) 49-58
28. Fried P.-A., Watkinson B., and Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marijuana, cigarettes and alcohol. Neurotoxicol. Teratol. 14 (1992) 299-311
29. Fried P.-A., Watkinson B., and Gray R. Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicol. Teratol. 20 (1998) 293-306
30. Fried P.-A., Watkinson B., and Gray R. Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana. Neurotoxicol. Teratol. 21 (1999) 513-525
31. Fried P.-A., and Smith A.-M. A literature review of the consequences of prenatal marijuana exposure: an emerging theme of a deficiency in aspects of executive function. Neurotoxicol. Teratol. 23 (2001) 1-11
32. Fried P.-A., Watkinson B., and Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marijuana. Neurotoxicol. Teratol. 25 (2003) 427-436
33. Fuster J.-M. The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. 2nd ed. (1989), Raven Press, New York, NY
34. 9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA-B, but not GABA-A, receptor agonist in adult rats. Neurotoxicol. Teratol. 21 (1999) 277-283
35. Giustino A., Cagiano R., Carratù M.-R., Cassano T., Tattoli M., and Cuomo V. Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring. Brain Res. 844 (1999) 201-205
36. Glass M., Dragunow M., and Faull R.-L.-M. Cannabinoid receptors in the human brain. A detailed anatomical quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77 (1997) 299-318
37. Goldschmidt L., Day N.-L., and Richardson G.-A. Effects of prenatal marijuana exposure on child behaviour problems at age 10. Neurotoxicol. Teratol. 22 (2000) 325-336
38. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., and Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 1071 (2006) 10-23
39. Goldsmith J.R. Contribution of motor vehicle exhaust, industry, and cigarette smoking to community carbon monoxide exposures. Ann. N.Y. Acad. Sci. 174 (1970) 122-134
40. Griffith D.-R., Azuma S.-D., and Chasnoff I.-J. Three-year outcome of children exposed prenatally to drugs. J. Am. Acad. Child Adolesc. Psychiatry 33 (1994) 20-27
41. Hajos N., and Freund T.F. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids 121 (2002) 73-82
42. Hausberg M., and Somers V.K. Neural circulatory responses to carbon monoxide in healthy humans. Hypertension 29 (1997) 1114-1118
43. Hoffman A.-F., Macgill A.-M., Smith D., Oz M., and Lupica C.-R. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur. J. Neurosci. 22 (2005) 2387-2391
44. Hutchings D.-E., Martin B.-R., Gamagaris Z., Miller N., and Fico T. Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 44 (1989) 697-701
45. Leech S.-L., Richardson G., Goldschmidt L., and Day N.-L. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol. Teratol. 21 (1999) 109-118
46. Lester B., and Dreher B.M. Effects of marijuana use during pregnancy on newborn cry. Child Dev. 60 (1989) 765-771
47. Lezak M.-D. Neuropsychological Assessment. 3rd ed. (1995), Oxford University Press, New York pp. 650-685
48. Mactutus C.-S., and Fechter L.-D. Prenatal exposure to carbon monoxide: learning and memory deficits. Science 223 (1984) 409-411
49. Martinez Orgado J.-A., Fernandez Lopez D., Bonet Serra B., Lizasoain Hernandez I., and Romero Paredes J. The cannabinoid system and its importance in the perinatal period. An. Pediatr. (Barc.) 63 (2005) 433-440
50. Mato S., Del Olmo E., and Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur. J. Neurosci. 17 9 (2003) 1747-1754
51. Mereu G., Cammalleri M., Fa M., Francesconi W., Saba P., Tattoli M., Trabace L., Vaccari A., and Cuomo V. Prenatal exposure to a low concentration of carbon monoxide disrupts hippocampal long-term potentiation in rat offspring. J. Pharmacol. Exp. Ther. 294 (2000) 728-734
52. Mereu G., Fa M., Ferraro L., Cagiano R., Antonelli T., Tattoli M., Ghiglieri V., Tanganelli S., Gessa G.-L., and Cuomo V. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4915-4920
53. 9-tetrahydrocannabinol on developing serotonergic system. Eur. J. Pharmacol. 316 (1996) 39-42
54. Navarro M., Rubio P., and de Fonseca F.-R. Behavioral consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology (Berl) 122 (1995) 1-14
55. Pistis M., Ferraro L., Pira L., Flore G., Tanganelli S., Gessa G.L., and Devoto P. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res. 948 (2002) 155-158
56. Richardson G., Day N., and Taylor P. The effect of prenatal alcohol, marijuana and tobacco exposure on neonatal behaviour. Inf. Behav. Dev. 12 (1989) 199-209
57. Rodriguez de Fonseca F., Cebeira M., Fernandez-Ruiz J.-J., Navarro M., and Ramos J.-A. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 43 (1991) 713-723
58. Rubio P., Rodriguez de Fonseca F., Martin-Calderon J.L., Del Arco I., Bartolome S., Villanua M.A., and Navarro M. Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring. Pharmacol. Biochem. Behav. 61 (1998) 229-238
59. Seamans J.-K., Nogueira L., and Lavin A. Synaptic basis of persistent activity in prefrontal cortex in vivo and in organotypic cultures. Cereb. Cortex 13 (2003) 1242-1250
60. Smith A.M., Fried P.-A., Hogan M.-J., and Cameron I. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol. Teratol. 26 (2004) 533-542
61. Storm J.-E., and Fechter L.-D. Prenatal carbon monoxide exposure differentially affects postnatal weight and monoamine concentration of rat brain regions. Toxicol. Appl. Pharmacol. 81 (1985) 139-146
62. Tennes K., Avitable N., Blackard C., Boyles C., Hassoun B., Holmes L., and Kreye M. Prenatal and postnatal exposure in the human. In: Pinkert T.M. (Ed). Current Research on the Consequences of Maternal Drug Abuse, National Institute on Drug Abuse Research Monograph No. 59 (1985), US Department of Health and Human Services, Rockville, MD 48-60
63. Tolcos M., McGregor H., Walker D., and Rees S. Chronic prenatal exposure to carbon monoxide results in a reduction in tyrosine hydroxylase-immunoreactivity and in an increase in choline acetyltransferase-immunoreactivity in the fetal medulla: implications for Sudden Infant Death Syndrome. J. Neuropathol. Exp. Neurol. 59 (2000) 218-228
64. Tomasini M.C., Ferraro L., Bebe B.W., Tanganelli S., Cassano T., Cuomo V., and Antonelli T. Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors. J. Neurosci. Res. 68 (2002) 449-453
65. Wang X., Dow-Edwards D., Keller E., and Hurd Y.-L. Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience 118 (2003) 681-694
66. Wu T.C., Tashkin D.P., Djahed B., and Rose J.E. Pulmonary hazards of smoking marijuana as compared with tobacco. N. Engl. J. Med. 318 (1988) 347-351